Crinetics Pharmaceuticals CRNX Return on invested capital

Return on invested capital at other companies

Neurocrine BiosciencesNBIX

17.5%+5.1pp

Corcept TherapeuticsCORT

1.1%-19.0pp

MBX Biosciences, Inc.MBX

-33%—

XER

Xeris Biopharma Holdings, Inc.XERS

21.7%+17.8pp

Viking TherapeuticsVKTX

-59.2%-292pp

Amylyx Pharmaceuticals, Inc.AMLX

-104.3%-16.8pp

FAQ

What is Crinetics Pharmaceuticals's return on invested capital?

Crinetics Pharmaceuticals (CRNX) reported return on invested capital of -45.1% in Q1 2026.

How has Crinetics Pharmaceuticals's return on invested capital changed year-over-year?

Crinetics Pharmaceuticals's return on invested capital decreased by 4.1% year-over-year, from -43.3% to -45.1%.

What is the long-term trend for Crinetics Pharmaceuticals's return on invested capital?

Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's return on invested capital has grown at a -11.3% compound annual growth rate (CAGR), from -91.9% to -50.4%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.